Sun Pharma inaugurates its manufacturing unit in Egypt
The Dollar Business Bureau On February 21, 2017, Indian Ambassador to Egypt Sanjay Bhattacharyya, inaugurated Sun Pharma’s manufacturing unit in 6th of October City in Cairo. Sun Pharma is an Indian multinational pharmaceutical company headquartered at Mumbai. The company manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulations in India and the US. Sun offers formulations in various therapeutic areas such as psychiatry, cardiology, neurology, diabetology, and gastroenterology. Sun Pharma is known for offering a wide range of healthcare products and medicines such as capsules, tablets, injectable, ointments, inhalers, creams, liquids and other dosages at affordable prices. The company has gained trust among healthcare professionals and patients across the globe. The third largest producer of pharmaceuticals in the world has started ...
Sun Pharma to terminate transaction pacts
The Dollar Business Bureau The Mumbai-based pharma major, Sun Pharmaceutical Industries has announced that they are terminating the umbrella pact and the transaction agreement signed with Daiichi Sankyo and its overseas subsidiaries. The termination comes as a result of the divestment of Ranbaxy by the Japanese firm. On May 26th, 2016, the companies Daiichi Sankyo (Thailand) Ltd, Daiichi Sankyo, Ranbaxy (Netherlands) BV, Ranbaxy (Thailand) Company Ltd and Sun Pharmaceutical Industries Ltd have entered into a termination agreement. Sun Pharma in a regulatory filing said, “the parties have terminated the umbrella agreement as well as the transaction agreements executed between Daiichi Sankyo Company Ltd, Daiichi Sankyo (Thailand) Ltd Ranbaxy, Ranbaxy (Netherlands) BV, Ranbaxy Unichem Company Ltd, Ranbaxy (Thailand) Company Ltd due to divestment of ...
Localisation is the secret behind the success of global brands: Nestle Exports
Neha Dewan | @TheDollarBiz Companies that plan to go global at times overlook the need to localise their products, and this often leads to failure, revealed Rakesh Sharma, Head of Exports, Nestle India, at a knowledge symposium on “Emerging Opportunities and Risk Management in Global Business” organised by the Federation of Indian Export Organisations (FIEO) and Jagan Institute of Management Studies (JIMS) in New Delhi last week. Speaking at the forum, Sharma said that identifying a consumer segment that resonates with the company’s core strength is an important factor for the success of a brand in emerging markets. However, localisation is the key. “One must develop products that are suitable for the local market. Localisation is critical to access. Failure ...
